Comments on AMA's view of pharmacists

In December, I received a large paper document from the American Medical Association (AMA) that was intended for use by the organization's state lobbyists and others to describe the scope of pharmacy practice. We were asked for comments, clarifications, and corrections.

I shared the document with a number of colleague pharmacy organizations. The holidays ensued and before we blinked, it was January. I was concerned that the information contained in it was dated at best, inaccurate, and perhaps damaging to pharmacy at worst. The primary contention was that physicians should be wary of collaborative practice agreements with pharmacists, as pharmacists are not typically well trained enough to trust with such roles.

I chose not to distribute the document broadly, in part due to the volume of paper involved, and in part due to the collaborative spirit in which Dr. Maves at AMA shared it with me. We began to gather comments from other pharmacy organizations so that we could share our collective views with AMA. The goal was to establish a meaningful dialogue, as we had been invited to do.

We have now submitted our comments to AMA. I am grateful to our colleague organizations for their thoughtful input. Together, we submitted what I believe to be excellent evidence and facts to support a more enlightened view by AMA. We also provided a detailed list of suggestions and have issued a joint news release.

In this process, we are not launching missiles. In fact, it is just the opposite. I had a very productive discussion with Dr. Maves this morning when we were both speakers at the US Pharmacopeia meeting in Washington. He acknowledged receipt of our comments, and we agreed to meet shortly to discuss next steps.

I believe our discussion will be productive. Pharmacy is not seeking turf from physicians. Rather, in the intrests of patient safety and quality care, we are focused on collaborative practices that meet needs not fully addressed by other health professionals. Pharmacy's positions will be backed up by evidence from the Institute of Medicine, numerous medical and pharmacy schools, extensive research and our own scope of practice research, as well as the research from numerous other colleagues in pharmacy and medicine.

I am confident these efforts will move the needle toward improved relationships and collaborative care. I hope you are with us in this effort.